RSMDF - Vivos Therapeutics: Reimagining Sleep

• Vivos Therapeutics' mission is to rid the world of obstructive sleep apnea (OSA).
• Vivos is doing this by reimagining how OSA gets treated. While Vivos' competitors focus on treating OSA symptoms, Vivos is trying to cure OSA.
• They are doing this by selling a product that slowly restructures the upper jaw, unblocking the airway to cure OSA. This product is a first-mover, has stickiness, and lots of demand.
• Because of their mission and their first-mover advantage, I believe that if Vivos' product sees mass adoption, this company could grow drastically and be a wonderful investment for very long-term-oriented investors.

For further details see: